EP1126857A4 - Verfahren zur aktivation von t-zellen sowie hierfür geeignete agentien - Google Patents

Verfahren zur aktivation von t-zellen sowie hierfür geeignete agentien

Info

Publication number
EP1126857A4
EP1126857A4 EP99970921A EP99970921A EP1126857A4 EP 1126857 A4 EP1126857 A4 EP 1126857A4 EP 99970921 A EP99970921 A EP 99970921A EP 99970921 A EP99970921 A EP 99970921A EP 1126857 A4 EP1126857 A4 EP 1126857A4
Authority
EP
European Patent Office
Prior art keywords
activating
cells
agents suitable
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP99970921A
Other languages
English (en)
French (fr)
Other versions
EP1126857A1 (de
Inventor
Louis Schofield
Diana Hansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Walter and Eliza Hall Institute of Medical Research
Original Assignee
Walter and Eliza Hall Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walter and Eliza Hall Institute of Medical Research filed Critical Walter and Eliza Hall Institute of Medical Research
Publication of EP1126857A1 publication Critical patent/EP1126857A1/de
Publication of EP1126857A4 publication Critical patent/EP1126857A4/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP99970921A 1998-10-27 1999-10-27 Verfahren zur aktivation von t-zellen sowie hierfür geeignete agentien Ceased EP1126857A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP6758A AUPP675898A0 (en) 1998-10-27 1998-10-27 A method of activating t cells and agents useful for same
AUPP675898 1998-10-27
PCT/AU1999/000929 WO2000024406A1 (en) 1998-10-27 1999-10-27 A method of activating t cells and agents useful for same

Publications (2)

Publication Number Publication Date
EP1126857A1 EP1126857A1 (de) 2001-08-29
EP1126857A4 true EP1126857A4 (de) 2004-04-14

Family

ID=3810974

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99970921A Ceased EP1126857A4 (de) 1998-10-27 1999-10-27 Verfahren zur aktivation von t-zellen sowie hierfür geeignete agentien

Country Status (3)

Country Link
EP (1) EP1126857A4 (de)
AU (1) AUPP675898A0 (de)
WO (1) WO2000024406A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP589398A0 (en) 1998-09-14 1998-10-08 Walter And Eliza Hall Institute Of Medical Research, The Immunogenic compositions and uses thereof
GB0015623D0 (en) * 2000-06-26 2000-08-16 Rademacher Group Limited Phosphoglycan messengers and their medical uses
GB0015627D0 (en) * 2000-06-26 2000-08-16 Rademacher Group Limited Phosphoglycan messengers and their medical uses
US8038986B2 (en) 2002-07-26 2011-10-18 The Walter And Eliza Hall Institute Of Medical Research Immunogenic compositions and diagnostic and therapeutic uses thereof
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
IL172175A0 (en) 2005-11-24 2011-08-01 Hadasit Med Res Service Beta glycolipids as immuno-modulators

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996034105A1 (en) * 1995-04-25 1996-10-31 Rmf Dictagene S.A. Modified polypeptides for enhanced immunogenicity
WO2000015254A1 (en) * 1998-09-14 2000-03-23 The Walter And Eliza Hall Institute Of Medical Research Immunogenic compositions and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002511421A (ja) * 1998-04-13 2002-04-16 ザ ブライハム アンド ウイミンズ ホスピタル， インコーポレイテッド Ｃｄ−１抗原およびｔ細胞刺激化合物を含むワクチン組成物およびその使用方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996034105A1 (en) * 1995-04-25 1996-10-31 Rmf Dictagene S.A. Modified polypeptides for enhanced immunogenicity
WO2000015254A1 (en) * 1998-09-14 2000-03-23 The Walter And Eliza Hall Institute Of Medical Research Immunogenic compositions and uses thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
SCHOFIELD L ET AL: "SIGNAL TRANSDUCTION IN HOST CELLS BY A GLYCOSYLPHOSPHATIDYLINOSITOLT PXOM OF MALARIA PARASITES", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, vol. 177, no. 1, 1 January 1993 (1993-01-01), pages 145 - 153, XP001010805, ISSN: 0022-1007 *
See also references of WO0024406A1 *
TACHADO S D ET AL: "SIGNAL TRANSDUCTION IN MACROPHAGES BY GLYCOSYLPHOSPHATIDYLINOSITOLSOF PLASMODIUM, TRYPANOSOMA, AND LEISHMANIA: ACTIVATION OF PROTEIN KINASE C BY INOSITOLGLYCAN AND DIACYLGLYCEROL MOIETIES", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 94, April 1997 (1997-04-01), pages 4022 - 4027, XP001002779, ISSN: 0027-8424 *
TACHADO SOUVENIR D ET AL: "Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-1-alpha and TNF-alpha expression in macrophages by protein tyrosine kinase mediated signal transduction", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 205, no. 2, 1994, &, pages 984 - 991, XP002269828, ISSN: 0006-291X *

Also Published As

Publication number Publication date
WO2000024406A1 (en) 2000-05-04
EP1126857A1 (de) 2001-08-29
AUPP675898A0 (en) 1998-11-19

Similar Documents

Publication Publication Date Title
DE69740113D1 (de) Vorrichtung und verfahren zur inkubation von zellen
DE59901706D1 (de) Einrichtung sowie Verfahren zur Bearbeitung von Bohrungen
DE69940804D1 (de) Verfahren und vorrichtung zur unterdrückung von abklingartefakten
DE69434913D1 (de) Verfahren und Vorrichtung zur Isolierung von Mikrogefässzellen
DE69940445D1 (de) Verfahren und Vorrichtung zur Editierung von skizzierten Kurven
DE59704406D1 (de) Verfahren zur temperierung von vorformlingen sowie vorrichtung zur temperierung
DE69837044D1 (de) Verfahren und Vorrichtung zur Versorgung von orthogonalen Strahlenbündeln, Sektoren und Picozellen
DE69816789D1 (de) Verfahren und system zur gestengesteuerten optionsauswahl
DE69815085D1 (de) System und verfahren zur klassifizierrung von zellproben
DE69827019D1 (de) Gerät und verfahren zur verarbeitung von biologischen zellen
DE69822687D1 (de) Vorrichtung und Verfahren zur Zusammenfassung
EP1009855A4 (de) Verfahren zur zelltrennung
DE69940321D1 (de) Zusammensetzung und verfahren zur identifizierung von retikulierten zellen
DE69903497D1 (de) Verfahren und Vorrichtung zur Unterdrückung von Resonanz
DE59803792D1 (de) Vorrichtung zur temperierung von vorformlingen sowie verfahren zur temperierung
DE69534886D1 (de) Verfahren zur Isolierung von Zellkomponenten
DE69822923D1 (de) Verfahren und Vorrichtung zur Kantenhervorhebung
DE69932526D1 (de) Verfahren zur homogenisierung
DE69931028D1 (de) Schneidanlage sowie verfahren zum schneiden
DE59900006D1 (de) Verfahren zur Isolierung von gekrümmten Flächen
DE69833478D1 (de) Verfahren und Vorrichtung zur Synchronworterkennung
DE69818981D1 (de) Vorrichtung und verfahren zur kristallisation
DE69812230D1 (de) Verfahren und vorrichtung zur herstellung von verbundplatten
ATE267169T1 (de) Verfahren zur herstellung von 3-alkanoyl- und 3- alkylindolen
DE59804931D1 (de) Verfahren zur selektiven hydrierung von ethylenisch ungesättigten doppelbindungen in polymerisaten

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010502

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 33/06 B

Ipc: 7A 61P 33/02 B

Ipc: 7A 61K 31/7032 B

Ipc: 7A 61K 39/015 B

Ipc: 7A 61K 39/008 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040302

17Q First examination report despatched

Effective date: 20050708

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20091019